查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1993888

基因组医疗保健市场：按类型、应用、技术、组件、最终用户、国家和地区划分－全球产业分析、市场规模、市场份额和预测（2026-2033 年）

Genomic Medicine Market, By Type, By Application, By Technology, By Component, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 328 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2025 年，基因组医学市场价值将达到 359.8498 亿美元，并预计从 2026 年到 2033 年将以 16.35% 的复合年增长率增长。

基因组医学是一种现代医疗保健方法，它利用个人基因（DNA）资讯来更有效地预防、诊断和治疗疾病。由于每个人都有独特的基因组成，研究这些基因差异能够帮助医疗专业人员了解为什么某些个体容易患上特定疾病或对治疗的反应各不相同。透过分析基因数据，医师可以及早识别疾病风险，并为每位患者提供更合适的治疗方案。这种方法有助于实现更个人化的医疗保健，尤其是在癌症治疗、罕见疾病诊断和药物选择等领域。

从全球观点来看，随着世界各国政府积极推动旨在改善医疗保健成果的国家基因倡议，基因组医学的应用正在不断扩展。例如，英国政府支持的「英格兰基因组学计画」（Genomics England）实施了「十万计划），该计画对约8.5万名罕见疾病和癌症患者的10万多个基因组进行了测序。此类政府主导的计划正在加强基因组研究的基础设施建设，并加速基因组技术在现代医疗保健系统中的临床应用。

基因组学市场—市场动态

精准医疗的普及正在加速市场扩张。

精准医疗的日益普及显着推动了基因组医学市场的发展。这种方法强调在製定治疗策略时充分考虑个体的遗传特征、生活方式和环境影响。基因测序和分子诊断技术的进步使医疗专业人员能够更深入地了解疾病机制，并选择更合适的治疗方法。随着医疗机构越来越多地采用个人化治疗模式，对基因组分析和基因检测的需求持续增长。此外，政府主导的基因组学相关倡议也正在推动医疗模式转向个人化。例如，英国卫生和社会保障部透过英国国家医疗服务体系（NHS）英格兰基因组服务中心支持基因组学项目，该中心在2023年进行了超过80万次基因组检测，透过支持癌症和罕见遗传疾病的诊断，加强了基于精准医疗的医疗服务。

除了政府主导的措施外，生物技术公司也在拓展基因组学，以支持个人化医疗的研究、开发和临床应用。例如，华大基因（BGI Genomics）报告称，其基因组学平台已在全球范围内处理数千万份定序样本，用于临床诊断、生殖健康筛检和疾病研究。这种大规模的基因组检测能力有助于识别基因变异和生物标记物，使医疗专业人员和研究人员能够开发标靶治疗和个人化治疗策略，从而促进精准医疗的广泛应用。

基因组医学市场—市场細項分析：

全球基因组学市场按类型、应用、技术、组件、最终用户和地区进行细分。

按类型划分，诊断基因组学预计仍将是医疗保健市场的重要组成部分，因为它在识别与多种疾病相关的基因变异方面发挥着至关重要的作用。基因测序和分子诊断技术在医疗保健系统中的日益普及，提高了临床医生早期发现遗传性疾病、罕见疾病和癌症的能力。诊断基因体学工具还能透过支援个人化治疗策略，帮助做出更精准的临床决策。例如，英国国家医疗服务体系 (NHS) 设立了“NHS 基因组学服务”，并将于 2024 年为患者进行超过 81 万次基因组检测。这其中包括针对 7000 多种罕见疾病和 200 多种癌症适应症的检测。这种不断扩展的临床应用表明，诊断基因组学在改善早期诊断和支持全球精准医疗策略方面的重要性日益凸显。

按组成部分划分，该市场可分为三大类：设备、耗材以及软体和服务。由于耗材在定序和基因组检测流程中持续使用，预计耗材将占据市场的大部分份额。试剂、定序盒、流动池和其他耗材是所有基因组实验和诊断测试的必需品，因此在实验室和研究机构中需求持续强劲。例如，Illumina公司报告称，其定序耗材在2023年的销售额约为39亿美元，这反映了其试剂和试剂盒在基因组研究和临床诊断中的广泛应用。这种持续的使用凸显了耗材对于支持大规模基因组检测和精准医疗应用的重要性。

基因组医疗保健市场—区域洞察

在全球医疗基础设施的进步、基因组研究倡议的不断增加以及政府鼓励精准医疗的政策推动下，全球基因组医学市场在多个地区呈现稳步增长。其中，北美凭藉其健全的製度框架和对基因组创新持续不断的投资，继续保持着重要的市场地位。政府和研究机构正积极推动基因测序、数据整合和个人化医疗方法。例如，美国国立卫生研究院（NIH）启动了「我们所有人」（All of Us）调查计画，旨在收集超过一百万名参与者的健康和基因信息，以支持精准医疗研究并改进个性化医疗策略。

在北美，美国透过政府和产业界的倡议，在基因组医学的发展中扮演着举足轻重的角色。据美国国立卫生研究院 (NIH) 称，在国家精准医疗倡议(NPMI) 的支持下，已从数十万参与者中生成了基因组数据集，为疾病研究和开发提供了支持。此外，Illumina 和 Thermo Fisher Scientific 等生技公司也持续拓展基因测序技术和分子诊断解决方案。例如，Illumina 报告称，其定序平台被用于产生全球相当一部分基因组数据，为世界各地的研究机构、医院和国家基因组计划提供支援。这些政府计画和产业发展共同巩固了美国的领先地位，并提升了北美在全球基因组医学市场的影响力。

日本基因组医学市场—各国概况

在日本，由于政府大力推动精准医疗和基因组研究，基因组医学市场正稳步扩张。厚生劳动省支持一项全国性的基因组学计划，旨在将遗传资讯整合到临床实践中，尤其是在癌症诊断和治疗方面。此外，日本医疗研究开发机构（AMED）持续资助旨在改善疾病预防和个人化医疗的大规模基因组研究计划，进一步加强日本的基因组医学生态系统。

此外，日本正在实施一系列国家基因组计划，例如由日本医疗研究开发机构（AMED）支持的“罕见疾病和未确诊疾病计划（IRUD）”，旨在提高罕见遗传疾病的诊断准确率。根据最新的政府计画信息，该计划已分析了数万名患者的基因组数据，以支持临床诊断和研究。同时，日本政府持续推动基因组数据的共用和先进医疗研究基础设施的建设，可望加速基因组医学在国内医疗体系中的普及和创新。

目录

第一章：基因组医学市场概览

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章：基因组医学的关键市场趋势

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 未来市场趋势

第四章：基因体医学产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长前景展望图
  • 管理体制分析

第五章：基因组医学市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：基因组医学市场现状

  • 基因组医学市占分析，2025年
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

第七章：基因组医学市场：依类型划分

  • 概述
    • 细分市场占有率分析：按类型
    • 预测基因组医学
    • 预防基因组医学
    • 诊断基因组医学
    • 治疗性基因组医学

第八章：基因组医学市场：依应用领域划分

  • 概述
    • 细分市场占有率分析：按应用
    • 肿瘤学
    • 罕见遗传疾病
    • 感染疾病
    • 药物基因体学
    • 其他的

第九章：基因组医学市场：依技术划分

  • 概述
    • 细分市场占有率分析：依技术划分
    • 次世代定序（NGS）
    • 聚合酵素链锁反应（PCR）
    • 微阵列
    • 基因编辑技术

第十章：基因组医学市场：依组成部分划分

  • 概述
    • 细分市场占有率分析：按组成部分
    • 装置
    • 消耗品
    • 软体服务
    • 其他的

第十一章：基因组医学市场：依最终用户划分

  • 概述
    • 细分市场占有率分析：依最终用户划分
    • 医院和诊所
    • 诊断检查室
    • 研究机构
    • 製药和生物技术公司

第十二章：基因组医学市场：依地区划分

  • 介绍
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 主要製造商：欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他欧洲国家
  • 亚太地区
    • 概述
    • 主要製造商：亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他亚太国家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他拉丁美洲国家
  • 中东和非洲
    • 概述
    • 主要生产商：中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他中东和非洲国家

第十三章：主要供应商分析：基因组学产业

  • 竞争基准
    • 竞争对手仪錶板
    • 竞争定位
  • 公司简介
    • BGI Genomics
    • Illumina
    • Thermo Fisher Scientific
    • F. Hoffmann-La Roche
    • QIAGEN
    • Agilent Technologies
    • BGI Genomics
    • Pacific Biosciences
    • Oxford Nanopore Technologies
    • Bio-Rad Laboratories
    • PerkinElmer
    • Myriad Genetics
    • Eurofins Scientific
    • Guardant Health
    • Natera
    • 23andMe, Inc.
    • Exact Sciences
    • Others

第十四章：分析师的综合视角

简介目录
Product Code: ANV6157

Genomic Medicine Market size was valued at US$ 35,984.98 Million in 2025, expanding at a CAGR of 16.35% from 2026 to 2033.

Genomic medicine is a modern healthcare approach that uses information from a person's genes (DNA) to help prevent, diagnose, and treat diseases more effectively. Since every individual has a unique genetic makeup, studying these genetic differences allows healthcare professionals to understand why certain people develop specific diseases or respond differently to treatments. By analyzing genetic data, doctors can identify disease risks at an early stage and provide treatments that are better suited to each patient. This approach supports more personalized healthcare, particularly in areas such as cancer treatment, rare disease diagnosis, and the selection of appropriate medications.

From a global perspective, the adoption of genomic medicine is expanding as governments promote national genome initiatives to improve healthcare outcomes. For instance, the Genomics England program, supported by the UK government, delivered the 100,000 Genomes Project, which sequenced more than 100,000 genomes from around 85,000 patients with rare diseases and cancers. These government-supported initiatives are strengthening genomic research infrastructure and accelerating the clinical integration of genomic technologies in modern healthcare systems.

Genomic Medicine Market- Market Dynamics

Growing adoption of precision medicine to accelerate market expansion

The increasing integration of precision medicine is contributing significantly to the advancement of the genomic medicine market. This approach emphasizes the development of treatment strategies that consider an individual's genetic characteristics, lifestyle patterns, and environmental influences. Progress in genomic sequencing and molecular diagnostic technologies allows healthcare professionals to gain deeper insights into disease pathways and select more appropriate therapeutic interventions. As healthcare providers increasingly adopt personalized treatment models, the demand for genomic analysis and genetic testing continues to expand. In addition, government-led genomic initiatives are supporting this transition toward individualized healthcare. For instance, the UK Department of Health and Social Care supports genomic programs through the NHS England Genomic Medicine Service, which performed over 800,000 genomic tests in 2023 to assist in diagnosing cancer and rare genetic disorders, reinforcing precision-based healthcare delivery.

In addition to government initiatives, biotechnology companies are expanding genomic technologies to support personalized medicine research and clinical adoption. For instance, BGI Genomics reported processing tens of millions of sequencing tests globally through its genomic platforms used in clinical diagnostics, reproductive health screening, and disease research. Such large-scale genomic testing capabilities support the identification of genetic variations and biomarkers, enabling healthcare providers and researchers to develop targeted therapies and individualized treatment strategies that reinforce the broader adoption of precision medicine.

Genomic Medicine Market- Segmentation Analysis:

The Global Genomic Medicine Market is segmented on the basis of Type, Application, Technology, Component, End User, and Region.

Based on Type, Diagnostic Genomic Medicine is likely to remain a key segment in the medicine market due to its critical role in identifying genetic variations associated with various diseases. The increasing adoption of genomic sequencing and molecular diagnostic technologies in healthcare systems has enhanced the ability of clinicians to detect genetic disorders, rare diseases, and cancer at an early stage. Diagnostic genomic tools also support more accurate clinical decision-making by enabling personalized treatment strategies. For instance, the NHS England established the NHS Genomic Medicine Service, which delivered over 810,000 genomic tests for patients in 2024, covering testing for more than 7,000 rare diseases and over 200 cancer indications. This expanding clinical application highlights the growing importance of diagnostic genomic medicine in improving early diagnosis and supporting precision healthcare strategies globally.

In terms of Component, this market is divided into three types: Instruments, Consumables and Software & Services. Consumables are predicted to account for a substantial portion of the market due to their continuous usage in sequencing and genomic testing workflows. Consumables such as reagents, sequencing kits, and flow cells are required for every genomic experiment or diagnostic test, creating recurring demand across laboratories and research institutions. For instance, Illumina reported that its sequencing consumables generated approximately $3.9 billion in revenue in 2023, reflecting the extensive use of reagents and kits in genomic research and clinical diagnostics. This consistent utilization highlights the importance of consumables in supporting large-scale genomic testing and precision medicine applications.

Genomic Medicine Market- Geographical Insights

The global genomic medicine market is experiencing steady expansion across several regions, supported by advancements in healthcare infrastructure, increased genomic research initiatives, and government policies encouraging precision medicine. Among these regions, North America continues to hold a significant position due to its strong institutional framework and sustained investments in genomic innovation. Government organizations and research institutions actively promote genomic sequencing, data integration, and personalized treatment approaches. For example, the National Institutes of Health introduced the All of Us Research Program, which aims to collect health and genetic information from over one million participants to support precision medicine research and improve individualized healthcare strategies.

Within North America, the United States plays a major role in advancing genomic medicine through both government and industry initiatives. According to the National Institutes of Health, genomic datasets from hundreds of thousands of participants have already been generated under national precision medicine initiatives, supporting disease research and therapeutic development. In addition, biotechnology companies such as Illumina and Thermo Fisher Scientific continue to expand genomic sequencing technologies and molecular diagnostic solutions. For example, Illumina has reported that its sequencing platforms have been used to generate the majority of the world's genomic data, supporting research laboratories, hospitals, and national genome projects worldwide. These government programs and industry developments collectively strengthen the United States' leadership and reinforce North America's influence in the global genomic medicine market.

Japan Genomic Medicine Market- Country Insights

In Japan, the genomic medicine market is steadily expanding due to strong government initiatives promoting precision healthcare and genomic research. The Ministry of Health, Labour and Welfare has supported nationwide genomic programs aimed at integrating genetic information into clinical practice, particularly in cancer diagnosis and treatment. In addition, the Japan Agency for Medical Research and Development (AMED) continues to fund large-scale genome research projects to improve disease prevention and personalized therapies, strengthening the country's genomic medicine ecosystem.

Japan has also implemented national genome initiatives such as the Initiative on Rare and Undiagnosed Diseases (IRUD), supported by AMED, to improve the diagnosis of rare genetic disorders. According to government program updates, the initiative has analyzed genomic data from tens of thousands of patients to support clinical diagnosis and research. Furthermore, the Japanese government continues to promote genomic data sharing and advanced medical research infrastructure, which is expected to enhance genomic medicine adoption and innovation within the country's healthcare system.

Genomic Medicine Market- Competitive Landscape:

Due to the continuous developments in genomic technologies and the increasing adoption of precision medicine, the global genomic medicine market is supported by the presence of both international biotechnology companies and emerging genomic solution providers, making it a extremely competitive industry. Companies offer their genomic platforms, sequencing technologies, and diagnostic solutions through direct sales channels, collaborations with healthcare institutions, research organizations, and pharmaceutical companies. Market participants compete on several factors including technological innovation, sequencing accuracy, data analysis capabilities, product reliability, and service availability. Key players such as Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, QIAGEN, and Agilent Technologies are focusing on strategies such as new product development, expansion of genomic research capabilities, strategic partnerships, and acquisitions to strengthen their market presence and expand their role in advancing genomic-based healthcare solutions.

Recent Developments:

In December 2025, Illumina entered into a collaboration and strategic investment agreement with MyOme to advance genomic health modeling and large-scale clinical trials using whole-genome sequencing and AI-integrated risk models. The partnership aims to enhance early disease detection and preventive healthcare strategies.

In October 2025, Thermo Fisher Scientific entered a strategic co-marketing agreement with Genovation Health and XYGene to expand access to integrated genomic testing solutions. The collaboration integrates microarray-based genomic data with clinical decision-support tools to accelerate precision medicine and pharmacogenomics applications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENOMIC MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • BGI Genomics
  • Illumina
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • QIAGEN
  • Agilent Technologies
  • BGI Genomics
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • Bio-Rad Laboratories
  • PerkinElmer
  • Myriad Genetics
  • Eurofins Scientific
  • Guardant Health
  • Natera
  • 23andMe, Inc.
  • Exact Sciences
  • Others

GLOBAL GENOMIC MEDICINE MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

  • Predictive Genomic Medicine
  • Preventive Genomic Medicine
  • Diagnostic Genomic Medicine
  • Therapeutic Genomic Medicine

GLOBAL GENOMIC MEDICINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Oncology
  • Rare Genetic Diseases
  • Infectious Diseases
  • Pharmacogenomics
  • Others

GLOBAL GENOMIC MEDICINE MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Gene Editing Technologies

GLOBAL GENOMIC MEDICINE MARKET, BY COMPONENT- MARKET ANALYSIS, 2020 - 2033

  • Instruments
  • Consumables
  • Software & Services
  • Others

GLOBAL GENOMIC MEDICINE MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical & Biotechnology Companies

GLOBAL GENOMIC MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Genomic Medicine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Genomic Medicine Market Snippet by Type
    • 2.1.2. Genomic Medicine Market Snippet by Application
    • 2.1.3. Genomic Medicine Market Snippet by Technology
    • 2.1.4. Genomic Medicine Market Snippet by Component
    • 2.1.5. Genomic Medicine Market Snippet by End User
    • 2.1.6. Genomic Medicine Market Snippet by Country
    • 2.1.7. Genomic Medicine Market Snippet by Region
  • 2.2. Competitive Insights

3. Genomic Medicine Key Market Trends

  • 3.1. Genomic Medicine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Genomic Medicine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Genomic Medicine Market Opportunities
  • 3.4. Genomic Medicine Market Future Trends

4. Genomic Medicine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genomic Medicine Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Genomic Medicine Market Landscape

  • 6.1. Genomic Medicine Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Genomic Medicine Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
    • 7.1.2. Predictive Genomic Medicine
    • 7.1.3. Preventive Genomic Medicine
    • 7.1.4. Diagnostic Genomic Medicine
    • 7.1.5. Therapeutic Genomic Medicine

8. Genomic Medicine Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Oncology
    • 8.1.3. Rare Genetic Diseases
    • 8.1.4. Infectious Diseases
    • 8.1.5. Pharmacogenomics
    • 8.1.6. Others

9. Genomic Medicine Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
    • 9.1.2. Next-Generation Sequencing (NGS)
    • 9.1.3. Polymerase Chain Reaction (PCR)
    • 9.1.4. Microarray
    • 9.1.5. Gene Editing Technologies

10. Genomic Medicine Market - By Component

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 10.1.2. Instruments
    • 10.1.3. Consumables
    • 10.1.4. Software & Services
    • 10.1.5. Others

11. Genomic Medicine Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 11.1.2. Hospitals & Clinics
    • 11.1.3. Diagnostic Laboratories
    • 11.1.4. Research Institutes
    • 11.1.5. Pharmaceutical & Biotechnology Companies

12. Genomic Medicine Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Genomic Medicine Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Genomic Medicine Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Genomic Medicine Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Genomic Medicine Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Genomic Medicine Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Genomic Medicine Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. BGI Genomics
    • 13.2.2. Illumina
    • 13.2.3. Thermo Fisher Scientific
    • 13.2.4. F. Hoffmann-La Roche
    • 13.2.5. QIAGEN
    • 13.2.6. Agilent Technologies
    • 13.2.7. BGI Genomics
    • 13.2.8. Pacific Biosciences
    • 13.2.9. Oxford Nanopore Technologies
    • 13.2.10. Bio-Rad Laboratories
    • 13.2.11. PerkinElmer
    • 13.2.12. Myriad Genetics
    • 13.2.13. Eurofins Scientific
    • 13.2.14. Guardant Health
    • 13.2.15. Natera
    • 13.2.16. 23andMe, Inc.
    • 13.2.17. Exact Sciences
    • 13.2.18. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us